Single-nucleotide polymorphisms and lung disease: Clinical implications

Chest

Volumn 131, Issue 4, 2007, Pages 1216-1223

  Tebbutt, Scott J ^a   James, Alan ^b   Paré, Peter D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Genetics; Genotyping; Lung disease; Pharmacogenetics; Single nucleotide polymorphism

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; HLA ANTIGEN; INTERLEUKIN 6; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; THEOPHYLLINE;

ACUTE LUNG INJURY; ALLERGY; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC REASONING; DISEASE PREDISPOSITION; DNA MICROARRAY; DNA SEQUENCE; DRUG CHOICE; DRUG RESPONSE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN GENOME; LIFESTYLE; LINKAGE ANALYSIS; LUNG DISEASE; NARCOLEPSY; PATHOGENESIS; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TOBACCO DEPENDENCE; TREATMENT RESPONSE; TUBERCULOSIS;

EID: 34247262207     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-2252     Document Type: Article

References (35)

1. Press RD, Bauer KA, Kujovich JL, et al. Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med 2002; 126:1304-1318
2. Schrijver I, Oitmaa E, Metspalu A, et al. Genotyping microarray for the detection of more than 200 CFTR mutations in ethnically diverse populations. J Mol Diagn 2005; 7:375-387
3. Shih JY, Gow CH, Yu CJ, et al. Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer. Int J Cancer 2006; 118:963-969
4. Mackay IM. Real-time PCR in the microbiology laboratory. Clin Microbiol Infect 2004; 10:190-212
5. Geremek M, Witt M. Primary ciliary dyskinesia: genes, candidate genes and chromosomal regions. J Appl Genet 2004; 45:347-361
6. Elliott CG. Genetics of pulmonary arterial hypertension: current and future implications. Semin Respir Crit Care Med 2005; 26:365-371
7. Nogee LM, Dunbar AE III, Wert SE, et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001; 344:573-579
8. Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun 2006; 7:95-100
9. Silverman EK. Progress in chronic obstructive pulmonary disease genetics. Proc Am Thorac Soc 2006; 3:405-408
10. Barnes KC. Genetic determinants and ethnic disparities in sepsis-associated acute lung injury. Proc Am Thorac Soc 2005; 2:195-201
11. Lander ES, Linton LM, Birron B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409:860-921
12. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273:1516-1517
13. Altshuler D, Brooks LD, Chakravarti A, et al. A haplotype map of the human genome. Nature 2005; 437:1299-1320
14. Ahmadian A, Gharizadeh B, Gustafsson AC, et al. Single-nucleotide polymorphism analysis by pyrosequencing. Anal Biochem 2000; 280:103-110
15. Tebbutt SJ, He JQ, Burkett KM, et al. Microarray genotyping resource to determine population stratification in genetic association studies of complex disease. Biotechniques 2004; 37:977-985
16. Kerem B, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073-1080
17. Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 1999; 65:220-228
18. Gilliland FD, Li YF, Saxon A, et al. Effect of glutathione-S-transferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: randomised, placebo-controlled crossover study. Lancet 2004; 363:119-125
19. Blakey J, Halapi E, Bjornsdottir US, et al. Contribution of ADAM33 polymorphisms to the population risk of asthma. Thorax 2005; 60:263-264
20. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004; 350:2129-2139
21. Han SW, Kim TY, Hwang PG, et al. Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol 2005; 23:2493-2501
22. Yong WP, Innocenti F, Ratain MJ. The role of pharmacogenetics in cancer therapies. Br J Clin Pharm 2006; 62:35-46
23. Shimizu Y, Dobashi K, Mita Y, et al. DNA microarray genotyping of N-acetyltransferase 2 polymorphism using carbodiimide as the linker for assessment of isoniazid hepatotoxicity. Tuberculosis (Edinb) 2006; 86:374-381
24. Marra CA, Esdaile JM, Anis AH. Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine. J Rheumatol 2002; 29:2507-2512
25. Weiss ST, Litonjua AA, Lange C, et al. Overview of the pharmacogenetics of asthma treatment. Pharmacogenomics J 2006; 6:311-326
26. Krejsa C, Rogge M, Sadee W. Protein therapeutics: new applications for pharmacogenetics. Nat Rev Drug Discov 2006; 5:507-521
27. Wechsler ME, Lehman E, Lazarus SC, et al, for National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. β-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med 2006; 173:519-526
28. Taylor DR, Drazen JM, Herbison GP, et al. Asthma exacerbations during long term β agonist use: influence of β(2) adrenoceptor polymorphism. Thorax 2000; 55:762-767
29. Lima JJ, Zhang S, Grant A, et al. Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am J Respir Crit Care Med 2006; 173:379-385
30. Obase Y, Shimoda T, Kawano T, et al. Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma. Clin Pharmacol Ther 2003; 73:468-474
31. Tantisira KG, Lake S, Silverman ES, et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 2004; 13:1353-1359
32. Lee AM, Tyndale RF. Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment. J Psychopharmacol 2006; 20(Suppl):7-14
33. Ogus AC, Yoldas B, Ozdemir T, et al. The Arg753Gln polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004; 23:219-223
34. Sutherland AM, Walley KR, Manocha S, et al. The association of interleukin 6 haplotype clades with mortality in critically ill adults. Arch Intern Med 2005; 165:75-82
35. Mignot E, Lin L, Rogers W, et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 2001; 68:686-699